New England Asset Management’s Medtronic MDT Stock Holding History

New England Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Hold	18,390	–	–	0.17%	83
2026 Q1	$1.59M	Hold	18,390	–	–	0.2%	80
2025 Q4	$1.77M	Buy	18,390 +825	+5%	+$80.1K	0.23%	80
2025 Q3	$1.67M	Hold	17,565	–	–	0.22%	84
2025 Q2	$1.53M	Hold	17,565	–	–	0.24%	83
2025 Q1	$1.58M	Hold	17,565	–	–	0.26%	85
2024 Q4	$1.4M	Hold	17,565	–	–	0.24%	87
2024 Q3	$1.58M	Sell	17,565 -1,235	-7%	-$104K	0.25%	84
2024 Q2	$1.48M	Hold	18,800	–	–	0.25%	83
2024 Q1	$1.64M	Hold	18,800	–	–	0.25%	82
2023 Q4	$1.55M	Hold	18,800	–	–	0.25%	83
2023 Q3	$1.47M	Sell	18,800 -3,144	-14%	-$263K	0.24%	80
2023 Q2	$1.93M	Hold	21,944	–	–	0.28%	81
2023 Q1	$1.77M	Hold	21,944	–	–	0.26%	80
2022 Q4	$1.71M	Sell	21,944 -1,896	-8%	-$154K	0.03%	94
2022 Q3	$1.93M	Hold	23,840	–	–	0.03%	84
2022 Q2	$2.14M	Buy	23,840 +1,896	+9%	+$192K	0.04%	78
2022 Q1	$2.44M	Hold	21,944	–	–	0.04%	80
2021 Q4	$2.27M	Sell	21,944 -500	-2%	-$57.9K	0.03%	80
2021 Q3	$2.81M	Hold	22,444	–	–	0.05%	70
2021 Q2	$2.79M	Hold	22,444	–	–	0.05%	70
2021 Q1	$2.65M	Hold	22,444	–	–	0.05%	72
2020 Q4	$2.63M	Hold	22,444	–	–	0.05%	68
2020 Q3	$2.33M	Buy	22,444 +100	+0.4%	+$10K	0.06%	69
2020 Q2	$2.05M	Hold	22,344	–	–	0.05%	70
2020 Q1	$2.02M	Buy	22,344 +400	+2%	+$42.6K	0.05%	66
2019 Q4	$2.49M	Hold	21,944	–	–	0.04%	70
2019 Q3	$2.38M	Hold	21,944	–	–	0.04%	69
2019 Q2	$2.14M	Hold	21,944	–	–	0.04%	75
2019 Q1	$2M	Buy	21,944 +900	+4%	+$80.6K	0.04%	77
2018 Q4	$1.91M	Sell	21,044 -3,584	-15%	-$335K	0.04%	72
2018 Q3	$2.42M	Hold	24,628	–	–	0.04%	69
2018 Q2	$2.11M	Sell	24,628 -2,216	-8%	-$185K	0.04%	71
2018 Q1	$2.15M	Sell	26,844 -1,200	-4%	-$99K	0.04%	68
2017 Q4	$2.26M	Sell	28,044 -2,200	-7%	-$176K	0.05%	66
2017 Q3	$2.35M	Hold	30,244	–	–	0.05%	63
2017 Q2	$2.68M	Sell	30,244 -4,800	-14%	-$405K	0.09%	49
2017 Q1	$2.82M	Sell	35,044 -2,200	-6%	-$172K	0.05%	59
2016 Q4	$2.65M	Buy	37,244 +755	+2%	+$59.3K	0.07%	44
2016 Q3	$3.15M	Buy	36,489 +2,200	+6%	+$192K	0.12%	34
2016 Q2	$2.98M	Sell	34,289 -800	-2%	-$64.7K	0.11%	35
2016 Q1	$2.63M	Hold	35,089	–	–	0.08%	42
2015 Q4	$2.7M	Sell	35,089 -11,500	-25%	-$866K	0.07%	45
2015 Q3	$3.12M	Sell	46,589 -7,700	-14%	-$567K	0.08%	51
2015 Q2	$4.02M	Sell	54,289 -1,811	-3%	-$138K	0.1%	35
2015 Q1	$4.38M	Buy	56,100 +10,400	+23%	+$788K	0.11%	37
2014 Q4	$3.3M	Sell	45,700 -68,300	-60%	-$4.74M	0.08%	47
2014 Q3	$7.06M	Sell	114,000 -4,100	-3%	-$261K	0.17%	40
2014 Q2	$7.53M	Sell	118,100 -3,800	-3%	-$231K	0.18%	39
2014 Q1	$7.5M	Sell	121,900 -200	-0.2%	-$11.7K	0.19%	36
2013 Q4	$7.01M	Sell	122,100 -200	-0.2%	-$11.3K	0.18%	43
2013 Q3	$6.51M	Sell	122,300 -7,300	-6%	-$393K	0.19%	40
2013 Q2	$6.67M	Buy	+129,600	New	+$6.41M	0.2%	37

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

New England Asset Management's MDT Position: Q2 2026 in Review

New England Asset Management held its Medtronic (MDT) position steady in Q2 2026 at 18,390 shares worth $1.44M. The position accounts for 0.17% of the portfolio, ranked #83.

New England Asset Management first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.53M in Q2 2014. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

New England Asset Management held 18,390 shares of Medtronic worth $1.44M as of Q2 2026.
New England Asset Management left its Medtronic share count unchanged in Q2 2026.
Medtronic made up 0.17% of New England Asset Management's portfolio in Q2 2026, its #83 holding.
New England Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
New England Asset Management's Medtronic position peaked at $7.53M in Q2 2014.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on New England Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.